BioNano Genomics, Inc. (BNGO) Posts Q3 Revenue of $2.8M

BioNano Genomics, Inc. (NASDAQ: BNGO) reported Q3 revenue of $2.8 million versus the consensus estimate of $2.45 million.

For earnings history and earnings-related data on BioNano Genomics, Inc. (BNGO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance